The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck

Current Treatment Options in Oncology

Volumn 15, Issue 4, 2014, Pages 611-624

  Hamoir, Marc ^a,b   Schmitz, Sandra ^a,b   Gregoire, Vincent ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Chemoradiotherapy; Head and neck cancer; Neck dissection; Neck metastases; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER CLASSIFICATION; CANCER CONTROL; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; GOLD STANDARD; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MORBIDITY; MOUTH CARCINOMA; NECK DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SURGEON; SURGICAL TECHNIQUE; TREATMENT INDICATION; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; INCIDENCE; LYMPH NODE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 84919914684     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-014-0311-7     Document Type: Review

References (87)

1. Woolgar JA, Triantafyllou A, Lewis Jr JS, et al. Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol. 2013;270:1581–92.
2. Rouvière H. Anatomie Humaine Descriptive et Topographique. 6th ed. Paris: Masson et Cie; 1948. p. 226–30.
3. Spiessl B, Beahrs OH, Hermanek P, et al. TNM Atlas. Illustrated Guide to the TNM/pTNM classification of malignant tumors. 3rd ed. Berlin: Springer; 1992.
4. Robbins KT, Medina JE, Wolfe GT, et al. Standardizing neck dissection terminology. Official report of the academy’s committee for head and neck surgery and oncology. Arch Otolaryngol Head Neck Surg. 1991;117:601–5.
5. Shah JP, Strong E, Spiro RH, et al. Surgical grand rounds. Neck dissection: current status and future possibilities. Clin Bull. 1981;11:25–33.
6. Hermanek P, Henson DE, Hutter RVP, et al., editors. TNM Supplement 1993. A commentary on uniform use. Berlin: Springer; 1993.
7. Lengele B, Hamoir M, Scalliet P, et al. Anatomical bases for the radiological delineation of lymph node areas, Part I. Major collecting trunks, head and neck. Radiother Oncol. 2007;85:146–55.
8. Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumours. 7th ed. Hoboken: Wiley-Blackwell; 2009.
9. O’Sullivan B, Shah J. New TNM staging criteria for head and neck tumors. Semin Surg Oncol. 2003;21:30–42.
10. Bataini JP, Bernier J, Brugere J, et al. Natural history of neck disease in patients with squamous cell carcinoma of the oropharynx and pharyngolarynx. Radiother Oncol. 1985;3:245–55.
11. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446–9.
12. Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12:197–203.
13. Candela FC, Shah J, Jaques DP, et al. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg. 1990;116:432–5.
14. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66:109–13.
15. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405–9.
16. Olzowy B, Tsalemchuk Y, Schotten KJ, et al. Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: a retrospective analysis of 352 cases after bilateral neck dissection. Head Neck. 2011;33:239–43.
17. Kowalski LP, Magrin J, Waksman G, et al. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch Otolaryngol Head Neck Surg. 1993;119:958–63.
18. Foote RL, Olsen KD, Davis DL, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck. 1993;15:300–7.
19. Byers RM. Neck dissection: concepts, controversies, and technique. Semin Surg Oncol. 1991;7:9–13.
20. Clayman GL, Frank DK. Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg. 1998;124:348–52.
21. Byers RM. Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg. 1985;150:414–21.
22. Spiro JD, Spiro RH, Shah JP, et al. Critical assessment of supraomohyoid neck dissection. Am J Surg. 1988;156:286–9.
23. Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin N Am. 1998;31:639–56.
24. Byers RM, Weber RS, Andrewa T, et al. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997;19:14–9.
25. De Zinis LO, Bolzoni A, Piazza C, et al. Prevalence and localization of nodal metastases in squamous cell carcinoma of the oral cavity: role and extension of neck dissection. Eur Arch Otorhinolaryngol. 2006;263:1131–5.
26. Dias FL, Lima RA, Kligerman J, et al. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg. 2006;134:460–5.
27. Marks JE, Devineni VR, Harvey J, et al. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol. 1992;13:34–9.
28. Capote-Moreno A, Naval L, Muñoz-Guerra MF, et al. Prognostic factors influencing contralateral neck lymph, node metastases in oral and oropharyngeal carcinoma. J Oral Maxillofac Surg. 2010;68:268–75.
29. Robbins KT. Integrating radiological criteria into the classification of cervical lymph node disease. Arch Otolaryngol Head Neck Surg. 1999;125:385–7.
30. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update. Revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751–8.
31. Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134:536–8.
32. Medina JE. A rational classification of neck dissections. Otolaryngol Head Neck Surg. 1989;100:169–76.
33. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965–9.
34. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer. 2001;91:2077–83.
35. Pitman KT, Johnson JT, Brown ML, et al. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope. 2002;112:2101–211.
36. Ross GL, Soutar DS, MacDonald DG, et al. Improved staging of cervical metastasis in clinically negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol. 2004;11:213–8.
37. Stoekli SJ, Pfalz M, Steinert H, et al. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope. 2002;112:111–5.
38. Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010;28:1395–400.
39. Govers TM, Hannink G, Merkx MA, Takes RP, Rovers MM. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol. 2013;49:726–32. This is the largest meta-analysis on sentinel lymph node biopsy published so far. Most of these patients had oral cavity squamous cell. The high sensitivity supports a role in the diagnostic work-up of oral squamous cell carcinoma.
40. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck. 2011;33:1260–4.
41. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.
42. Brazilian Head and Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg. 1998;176:422–7.
43. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg. 1988;10:160–7.
44. Byers RM, Clayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract. Patterns of regional failure. Head Neck. 1999;21:499–505.
45. Duvvuri U, Simental Jr AA, D’Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope. 2004;114:2228–34.
46. Jesse RH, Ballantyne AJ, Larson D. Radical or modified neck dissection. A therapeutic dilemma. Am J Surg. 1978;136:516–9.
47. Lingeman RE, Helmus C, Stephens R, et al. Neck dissection. Radical or conservative. Ann Otol. 1977;86:737–44.
48. Medina JE, Byers RM. Supraomohyoid neck dissection. Rationale, indications, and surgical technique. Head Neck. 1989;11:111–22.
49. Pellitteri PK, Robbins KT, Neuman T. Expanded application of selective neck dissection with regard to nodal status. Head Neck. 1997;19:260–5.
50. Pitman KT, Johnson JT, Myers EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg. 1997;123:917–22.
51. Spiro RH, Morgan GJ, Strong EW, et al. Supraomohyoid neck dissection. Am J Surg. 1996;172:650–3.
52. Schmitz S, Machiels JP, Weynand B, et al. Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2009;266:437–43.
53. Andersen PE, Shah JP, Cambronero E, et al. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg. 1994;168:499–502.
54. Carew JF, Singh B, Shah JP. Cervical lymph nodes. In: Shah JP, Johnson NW, Batsakis JG, Dunitz M, editors. Oral cancer. New York: Thieme; 2003. p. 215–49.
55. Khafif RA, Gelbfish GA, Asase DK, et al. Modified radical neck dissection in cancer of the mouth, pharynx, and larynx. Head Neck. 1990;12:476–82.
56. Shah JP. Cervical lymph node metastases—diagnostic, therapeutic, and prognostic implications. Oncology. 1990;4:61–9.
57. Clark J, Li W, Smith G, et al. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma. Head Neck. 2005;27:87–94.
58. Shaha AR. Extended neck dissection. J Surg Oncol. 1990;45:229–33.
59. Brennan JA, Jafek BW. Elective carotid artery resection for advanced squamous cell carcinoma of the neck. Laryngoscope. 1994;104:259–63.
60. Maves MD, Bruns MD, Keenan MJ. Carotid artery resection for head and neck cancer. Ann Otol Rhinol Laryngol. 1992;101:778–81.
61. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
62. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845–52.
63. Narayan K, Crane CH, Kleid S, et al. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy. For some or for all? Head Neck. 1999;21:606–13.
64. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000;126:950–6.
65. Clayman GL, Johnson II CJ, Morrison W, et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127:135–9.
66. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck. 2003;25:791–8.
67. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418–23.
68. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26:447–55.
69. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:526–31.
70. Forest VI, Nguyen-Tan PF, Tabet JC, et al. Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma. Head Neck. 2006;28:1099–105.
71. Vedrine PO, Thariat J, Hitier M, et al. Need for neck dissection after chemoradiotherapy? A study of the French GETTEC Group. Laryngoscope. 2008;118:1775–80.
72. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009;31:328–37.
73. Corry J, Peters L, Fisher R, et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck. 2008;30:737–42.
74. Hamoir M, Ferlito A, Schmitz S, et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol. 2012;48:203–10. This article reviews all the available literature on the role of neck dissection after chemoradiotherapy in patients with head and neck squamous cell carcinoma with advanced regional disease. Because of the availability of improved diagnostic follow-up modalities, there are many arguments supporting that planned neck dissection is no longer necessary for patients with complete response.
75. Lambrecht M, Dirix P, Van den Bogaert W, Nuyts S. Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma. Radiother Oncol. 2009;93:498–502.
76. Waldron JN, Gilbert RW, Eapen L, et al. Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC). J Clin Oncol. 2011;29(Suppl): [Abstract 5504].
77. Yao M, Hoffman HT, Chang K, et al. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Int J Radiat Oncol Biol Phys. 2007;68:707–13.
78. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck. 2005;27:175–81.
79. Ong SC, Schöder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med. 2008;49:532–40.
80. Porceddu S, Pryor DI, Burmeister E, et al. Results of a prospective study of positron emission tomography-directed management of residual abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck. 2011;33:1675–82. This prospective study demonstrates that PET-directed management of the neck after definitive chemoradiotherapy in N+ head and neck squamous cell carcinoma appropriately spares neck dissections in patients with PET-negative, residual nodal abnormalities without compromising isolated nodal control.
81. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection. Significance of radiation dose. Laryngoscope. 2006;116:33–6.
82. Doweck I, Robbins KT, Mendenhall WM, et al. Neck-level-specific nodal metastases in oropharyngeal cancer. Is there any role for selective neck dissection after definitive radiotherapy? Head Neck. 2003;25:960–7.
83. Mukhija V, Gupta S, Jacobson AS, Anderson Eloy J, Genden EM. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck. 2009;31:183–8.
84. Dhiwakar M, Robbins KT, Vieira F, Rao K, Malone J. Selective neck dissection as an early salvage intervention for clinically persistent nodal disease following chemoradiation. Head Neck. 2012;34:188–93. This is a retrospective study on patients who subsequently underwent selective neck dissections for early salvage of clinically persistent nodal disease after definitive chemoradiation for advanced head and neck squamous cell carcinoma. Recurrence in the dissected neck was reported in only one patient. Although retrospective, these data show that selective neck dissection is an effective early salvage intervention for persistent nodal disease in patients treated with chemoradiation.
85. Robbins KT, Dhiwakar M, Vieira F, Rao K, Malone J. Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer. Oral Oncol. 2012;48:1185–9. This retrospective study on 30 patients shows that superselective neck dissection is an effective intervention for patients with advanced head and neck cancer treated with chemoradiation whose risk for residual nodal disease is confined to one level.
86. Proctor E, Robbins KT, Viera F, et al. Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck. 2004;26:272–7.
87. Hillel AT, Fakhry C, Pai SI, et al. Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;141:737–42.